The Anti-Inflammatory Mechanism of Prostaglandin E2 Receptor 4 Activation in Rat Experimental Autoimmune Myocarditis

Prostaglandins (PG) and their specific receptors for E type PG (EP) play an important role in inflammatory diseases. Although myocarditis results in inflammation of the heart, roles of PG and EP in its pathophysiology is still controversial. To clarify the role of PG and EP on the progression of myocarditis, we used an experimental autoimmune myocarditis model. A selective EP4 (EP4RAG) agonist was administered into both early (Day 0 to 21) and late (Day 14 to 21) -treated groups and the animals were killed on Day 21. We found that improved cardiac function was detected in the EP4RAG-treated groups in comparison to the untreated group. The infiltration area ratio in the early-treated (16.6% ± 4.6%) group was lower than those in the untreated group (32.1% ± 3.5%) (P < 0.05). The fibrosis area ratios in the early-treated (19.2% ± 6.3%) and the late-treated groups (24.4% ± 5.1%) were lower than those in the untreated group (37.4% ± 2.6%), respectively (P < 0.05). Moreover, we found that EP4RAG decreased T-cell proliferation and monocyte chemoattractant protein-1 production in vitro. We concluded that a selective EP4 agonist inactivates T-cells, which turns out to moderate the progression of experimental autoimmune myocarditis. Therefore, EP4 can be an effective target for myocarditis treatment.

[1]  M. Isobe,et al.  The Mechanism of Anti-Inflammatory Effects of Prostaglandin E2 Receptor 4 Activation in Murine Cardiac Transplantation , 2009, Transplantation.

[2]  M. Isobe,et al.  Pharmacological activation of the prostaglandin E2 receptor EP4 improves cardiac function after myocardial ischaemia/reperfusion injury. , 2009, Cardiovascular research.

[3]  P. Libby,et al.  Prostaglandin E Receptor Type 4-associated Protein Interacts Directly with NF-κB1 and Attenuates Macrophage Activation* , 2008, Journal of Biological Chemistry.

[4]  M. Isobe,et al.  Tea catechins improve left ventricular dysfunction, suppress myocardial inflammation and fibrosis, and alter cytokine expression in rat autoimmune myocarditis , 2007, European journal of heart failure.

[5]  M. Isobe,et al.  A cyclooxygenase-2 inhibitor alters Th1/Th2 cytokine balance and suppresses autoimmune myocarditis in rats. , 2006, Journal of molecular and cellular cardiology.

[6]  Makoto Murakami,et al.  Prostaglandin E synthase: a novel drug target for inflammation and cancer. , 2006, Current pharmaceutical design.

[7]  Q. Myrvik,et al.  Splenic PGE2‐releasing macrophages regulate Th1 and Th2 immune responses in mice treated with heat‐killed BCG , 2005, Journal of leukocyte biology.

[8]  T. Kanda,et al.  Inhibition of cyclooxygenase-2 enhances myocardial damage in a mouse model of viral myocarditis. , 2005, Life sciences.

[9]  K. Hirao,et al.  Hepatocyte Growth Factor Ameliorates the Progression of Experimental Autoimmune Myocarditis: A Potential Role for Induction of T Helper 2 Cytokines , 2005, Circulation research.

[10]  D. Aronoff,et al.  Prostaglandin E2 Inhibits Alveolar Macrophage Phagocytosis through an E-Prostanoid 2 Receptor-Mediated Increase in Intracellular Cyclic AMP12 , 2004, The Journal of Immunology.

[11]  S. Oparil,et al.  Volume overload results in exaggerated cardiac hypertrophy in the atrial natriuretic peptide knockout mouse. , 2004, Cardiovascular research.

[12]  G. Verleden,et al.  Modulation by cAMP of IL‐1β‐induced eotaxin and MCP‐1 expression and release in human airway smooth muscle cells , 2003, European Respiratory Journal.

[13]  M. Isobe,et al.  Attenuation of experimental autoimmune myocarditis by blocking activated T cells through inducible costimulatory molecule pathway. , 2003, Cardiovascular research.

[14]  P. Libby,et al.  Prostaglandin E2 Suppresses Chemokine Production in Human Macrophages through the EP4 Receptor* , 2002, The Journal of Biological Chemistry.

[15]  R. Phipps,et al.  Prostaglandins as modulators of immunity. , 2002, Trends in immunology.

[16]  B. Koller,et al.  Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes. , 2001, The Journal of clinical investigation.

[17]  P. Kang,et al.  The conserved phosphoinositide 3‐kinase pathway determines heart size in mice , 2000, The EMBO journal.

[18]  C. Kawai,et al.  From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future. , 1999, Circulation.

[19]  G. Delespesse,et al.  Prostaglandin E2 primes naive T cells for the production of anti‐inflammatory cytokines , 1997, European journal of immunology.

[20]  D. Adams,et al.  Chemokines: leucocyte recruitment and activation cytokines , 1997, The Lancet.

[21]  M. Matsuzaki,et al.  Nitric oxide contributes to the progression of myocardial damage in experimental autoimmune myocarditis in rats. , 1997, Circulation.

[22]  R. Phipps,et al.  Prostaglandin E2 receptors of the EP2 and EP4 subtypes regulate activation and differentiation of mouse B lymphocytes to IgE-secreting cells. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[23]  K. Furusho,et al.  Prostaglandin E2 at priming of naive CD4+ T cells inhibits acquisition of ability to produce IFN-gamma and IL-2, but not IL-4 and IL-5. , 1995, Journal of immunology.

[24]  M. Kodama,et al.  Localization of porcine cardiac myosin epitopes that induce experimental autoimmune myocarditis. , 1995, Circulation research.

[25]  L. Aarden,et al.  Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production , 1995, The Journal of experimental medicine.

[26]  M. Kodama,et al.  Rat dilated cardiomyopathy after autoimmune giant cell myocarditis. , 1994, Circulation research.

[27]  W. Hickey,et al.  Identification of myocarditogenic peptides derived from cardiac myosin capable of inducing experimental allergic myocarditis in the Lewis rat. The utility of a class II binding motif in selecting self-reactive peptides. , 1994, Journal of immunology.

[28]  T. Mak,et al.  The induction of experimental autoimmune myocarditis in mice lacking CD4 or CD8 molecules [corrected] [published erratum appears in J Exp Med 1994 Jan 1;179(1):371] , 1993, The Journal of experimental medicine.

[29]  M. Kodama,et al.  In Vivo Lymphocyte‐Mediated Myocardial Injuries Demonstrated by Adoptive Transfer of Experimental Autoimmune Myocarditis , 1992, Circulation.

[30]  N. Neu,et al.  Cellular infiltrate, major histocompatibility antigen expression and immunopathogenic mechanisms in cardiac myosin-induced myocarditis. , 1991, Laboratory investigation; a journal of technical methods and pathology.

[31]  P. Allen,et al.  Myosin-induced acute myocarditis is a T cell-mediated disease. , 1991, Journal of immunology.

[32]  Y. Yazaki,et al.  Expression of Perforin in Infiltrating Cells in Murine Hearts With Acute Myocarditis Caused by Coxsackievirus B3 , 1991, Circulation.

[33]  M. Kodama,et al.  A novel experimental model of giant cell myocarditis induced in rats by immunization with cardiac myosin fraction. , 1990, Clinical immunology and immunopathology.

[34]  K. Beisel,et al.  Cardiac myosin induces myocarditis in genetically predisposed mice. , 1987, Journal of immunology.

[35]  P. Lodge,et al.  Coxsackievirus B-3 myocarditis in Balb/c mice. Evidence for autoimmunity to myocyte antigens. , 1984, The American journal of pathology.